Mississippi Attorney General Sues Both Pharma and PBMs as Insulin Prices Soar
Mississippi has accused insulin manufacturers and pharmacy benefit managers (PBMs) of working together to maintain insulin prices unmanageably high. Mississippi [...]
White Paper Details Pharmacoeconomics Analysis Considerations
A new white paper, provided by Dr. Nina Lathia, details the critical elements of an effective pharmacoeconomics (PE) analysis. Dr. [...]
Register Today for Upcoming AMCP Webinar on the Biosimilar Landscape in the United States
The Academy of Managed Care Pharmacy (AMCP) will host a virtual event on biosimilars. The webinar will detail steps than [...]
Senate Democrats Discuss Alternative Drug Pricing Bill; Pelosi’s Bill Could Lead to $500 Billion in Savings
Senate Democrats are considering a new proposal to reduce drug prices. New Jersey’s Senator Bob Menendez noted that despite efforts [...]
PRMA Consulting Webinar Discusses Strengthening GVDs
PRMA is offering an on-demand webinar on global value dossiers (GVDs). Suboptimal GVDs can lead to misused time and resources, [...]
PRMA Consulting Offers Regenerative Medicine and Rare Disease Market Access Insight
PRMA Consulting is offering a selection of case studies that reflect the challenges facing stakeholders when considering market access strategies [...]
FDA Turns Down Verily’s Application to Monitor Parkinson’s Disease Using Smartwatch
The Food and Drug Administration (FDA) has rejected Verily’s application to use a smartwatch to assess the severity of Parkinson’s [...]
Incoming NPC President and CEO Emphasizes Interdisciplinary Collaboration to Improve Healthcare
John O’Brien took on the positions of president and CEO of the National Pharmaceutical Council (NPC) on June 1st, 2021. [...]
Considerations for Biotech Investors Include a Robust Market Access Strategy and Value-Based Pricing
Market access expert Colin Wight details ten key considerations for investors in biotechnology and biopharma. He notes that implementing a [...]
Syneos Health Unveils Patient Voice Consortium to Improve R&D Pipeline
Syneos Health has announced the launch of its Patient Voice Consortium, intended to highlight the patient perspective throughout the drug [...]
McKesson Announces CoverMyMeds’ Strategical Expansion, Leading to Lower Patient Costs
McKesson has announced that CoverMyMeds will encompass RelayHealth, McKesson Prescription Automation, and RxCrossroads by McKesson. This shift is expected to [...]
Prescription Drug Discount Services Not Always Patient-Centered
One of the many ways to purchase prescription drugs is to use a discount program, such as GoodRx or Amazon [...]
ESG Measures Could Incorporate Drug Pricing Data
Environment, social, and governance (ESG) measures indicate how pharmaceutical companies consider the global impact of their policies. Now, some analysts [...]
Tufts HEOR Certificate Program Taking Applications
The Tufts Graduate School of Biomedical Sciences and Clinical and Translational Science offers a Health Economics and Outcomes Research (HEOR) [...]
[Whitepaper] Sensors Provide Useful RWD in Clinical Trials
The use of sensors and wearables in clinical trials is rapidly increasing, a trend that has been accelerated by the [...]
Medicaid Improves Patient Access to Hepatitis C Drugs in Majority of States
State Medicaid programs made it easier for patients to access hepatitis C medication. These changes take into consideration the stage [...]
Could Payer Push for Innovative Contracts Lead to Lower Patient Costs?
Results from a survey by Verpora indicate that payers consider innovative contracts to be a robust cost-saving measure capable of [...]
Updated Specialty Pharmacy Database Includes More Than 1,125 Pharmacy Locations
Syringe with glass vials and medications pills drug Access Market Intelligence’s Specialty Pharmacy Database has been modified to [...]
DTx’s coverage conundrum
Makers of digital therapeutics (DTx) are raising huge sums from investors to treat patients with everything from insomnia, to substance [...]
Biosimilar Market to Hit $178 Billion in 2024
In 2006, the European Medicines Agency approved its first biosimilar. Omnitrope was developed in cases of growth hormone deficiency. Now, [...]
Fate of Biogen’s Alzheimer’s Disease Drug Remains Uncertain
Biogen is awaiting the Food and Drug Administration’s decision regarding its Alzheimer’s disease drug, aducanumab. However, mixed data regarding the [...]
Woman to Woman Podcast Series Highlights Senior HEOR Researcher
Divya Yerraguntla hosts a podcast series that highlights the stories of women who have broken through barriers to succeed in [...]
BCG Report on Using RWE in Clinical Trials
A Boston Consulting Group (BCG) report discusses the benefits of real world evidence (RWE) in streamlining the clinical trial pipeline. [...]
New Report Claims Reducing Drug Prices Will Not Impact Innovation, Discusses HTA Solution
Patients for Affordable Drugs released a report on how lowering drug prices would fail to impact innovation. The authors note [...]
ICER’s Protocol on Unsupported Price Increases Discusses 250 Drugs
The Institute for Clinical and Economic Review (ICER) recently published a protocol detailing how it determines unjustified price increases. The [...]